Avicanna Provides Corporate Update and Preliminary Q2 Results
TORONTO, June 28, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and comm…